A detailed history of Rhumbline Advisers transactions in Seer, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 88,025 shares of SEER stock, worth $147,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88,025
Previous 84,573 4.08%
Holding current value
$147,882
Previous $164,000 1.83%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$1.54 - $2.09 $5,316 - $7,214
3,452 Added 4.08%
88,025 $167,000
Q4 2023

Feb 08, 2024

BUY
$1.47 - $2.22 $767 - $1,158
522 Added 0.62%
84,573 $164,000
Q3 2023

Nov 09, 2023

BUY
$2.18 - $5.52 $5,290 - $13,397
2,427 Added 2.97%
84,051 $185,000
Q2 2023

Aug 08, 2023

BUY
$3.16 - $4.96 $12,140 - $19,056
3,842 Added 4.94%
81,624 $348,000
Q1 2023

May 11, 2023

SELL
$3.6 - $5.88 $2,030 - $3,316
-564 Reduced 0.72%
77,782 $300,000
Q4 2022

Feb 14, 2023

BUY
$5.03 - $8.58 $9,330 - $15,915
1,855 Added 2.43%
78,346 $454,000
Q3 2022

Nov 10, 2022

BUY
$7.7 - $13.31 $32,301 - $55,835
4,195 Added 5.8%
76,491 $592,000
Q2 2022

Aug 11, 2022

BUY
$6.72 - $16.07 $163,390 - $390,725
24,314 Added 50.67%
72,296 $647,000
Q1 2022

May 12, 2022

SELL
$11.88 - $23.4 $31,232 - $61,518
-2,629 Reduced 5.19%
47,982 $731,000
Q4 2021

Feb 10, 2022

BUY
$21.08 - $38.51 $2,909 - $5,314
138 Added 0.27%
50,611 $1.15 Million
Q3 2021

Nov 12, 2021

BUY
$27.67 - $45.04 $940,503 - $1.53 Million
33,990 Added 206.21%
50,473 $1.74 Million
Q2 2021

Aug 05, 2021

BUY
$28.75 - $56.92 $79,436 - $157,269
2,763 Added 20.14%
16,483 $540,000
Q1 2021

May 06, 2021

BUY
$38.67 - $84.06 $530,552 - $1.15 Million
13,720 New
13,720 $686,000

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $98.4M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.